Moderna, Inc.

/Moderna, Inc.


Moderna, Inc.

We are creating a new category of transformative medicines based on messenger RNA, or mRNA, to improve the lives of patients. From the beginning, we designed our strategy and operations to realize the full potential value and impact of mRNA over a long time horizon across a broad array of human diseases.



Final Price

Final Shares

Effective Date
December 7, 2018

Morgan Stanley, Goldman Sachs & Co. LLC, J.P. Morgan, BofA Merrill Lynch, Barclays, Piper Jaffray, Bryan, Garnier & Co., Oddo BHF, Oppenheimer & Co., Needham & Company, Chardan

To view the prospectus for Moderna, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange